Cargando…
Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875289/ https://www.ncbi.nlm.nih.gov/pubmed/36712991 http://dx.doi.org/10.3389/fchem.2022.1131801 |
| _version_ | 1784877933321519104 |
|---|---|
| author | Shawish, Ihab Nafie, Mohamed S. Barakat, Assem Aldalbahi, Ali Al-Rasheed, Hessa H. Ali, M. Alshaer, Walhan Al Zoubi, Mazhar Al Ayoubi, Samha De La Torre, Beatriz G. Albericio, Fernando El-Faham, Ayman |
| author_facet | Shawish, Ihab Nafie, Mohamed S. Barakat, Assem Aldalbahi, Ali Al-Rasheed, Hessa H. Ali, M. Alshaer, Walhan Al Zoubi, Mazhar Al Ayoubi, Samha De La Torre, Beatriz G. Albericio, Fernando El-Faham, Ayman |
| author_sort | Shawish, Ihab |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9875289 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98752892023-01-26 Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors Shawish, Ihab Nafie, Mohamed S. Barakat, Assem Aldalbahi, Ali Al-Rasheed, Hessa H. Ali, M. Alshaer, Walhan Al Zoubi, Mazhar Al Ayoubi, Samha De La Torre, Beatriz G. Albericio, Fernando El-Faham, Ayman Front Chem Chemistry Frontiers Media S.A. 2023-01-11 /pmc/articles/PMC9875289/ /pubmed/36712991 http://dx.doi.org/10.3389/fchem.2022.1131801 Text en Copyright © 2023 Shawish, Nafie, Barakat, Aldalbahi, Al-Rasheed, Ali, Alshaer, Al Zoubi, Al Ayoubi, De La Torre, Albericio and El-Faham. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Chemistry Shawish, Ihab Nafie, Mohamed S. Barakat, Assem Aldalbahi, Ali Al-Rasheed, Hessa H. Ali, M. Alshaer, Walhan Al Zoubi, Mazhar Al Ayoubi, Samha De La Torre, Beatriz G. Albericio, Fernando El-Faham, Ayman Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title | Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title_full | Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title_fullStr | Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title_full_unstemmed | Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title_short | Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| title_sort | corrigendum: pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors |
| topic | Chemistry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875289/ https://www.ncbi.nlm.nih.gov/pubmed/36712991 http://dx.doi.org/10.3389/fchem.2022.1131801 |
| work_keys_str_mv | AT shawishihab corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT nafiemohameds corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT barakatassem corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT aldalbahiali corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT alrasheedhessah corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT alim corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT alshaerwalhan corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT alzoubimazhar corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT alayoubisamha corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT delatorrebeatrizg corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT albericiofernando corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors AT elfahamayman corrigendumpyrazolylstriazinewithindolemotifasanovelofepidermalgrowthfactorreceptorcyclindependentkinase2dualinhibitors |